Does CATEQUENTINIB Cause Myelosuppression? 84 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Myelosuppression have been filed in association with CATEQUENTINIB. This represents 25.9% of all adverse event reports for CATEQUENTINIB.
84
Reports of Myelosuppression with CATEQUENTINIB
25.9%
of all CATEQUENTINIB reports
5
Deaths
35
Hospitalizations
How Dangerous Is Myelosuppression From CATEQUENTINIB?
Of the 84 reports, 5 (6.0%) resulted in death, 35 (41.7%) required hospitalization, and 8 (9.5%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CATEQUENTINIB. However, 84 reports have been filed with the FAERS database.
What Other Side Effects Does CATEQUENTINIB Cause?
Off label use (37)
Diarrhoea (33)
Hypertension (26)
Nausea (26)
Vomiting (26)
Rash (25)
Thrombocytopenia (24)
Fatigue (23)
Anaemia (22)
Decreased appetite (22)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which CATEQUENTINIB Alternatives Have Lower Myelosuppression Risk?
CATEQUENTINIB vs CC-4047
CATEQUENTINIB vs CEDAZURIDINE\DECITABINE
CATEQUENTINIB vs CEDIRANIB
CATEQUENTINIB vs CEFACLOR
CATEQUENTINIB vs CEFADROXIL